October 8, 2026
How many mg is 40 units of semaglutide?
Forty units on a U-100 syringe is 0.4 mL, so 40 units of semaglutide is 0.4 mg at 1 mg/mL, 1 mg at 2.5 mg/mL and 2 mg at 5 mg/mL. Full table.
Read moreGLP-1 Weight Loss Blog
Guides on dosing, expected results and what the clinical trials actually show.
October 5, 2026
How long does it take to lose 50 pounds on a GLP-1?
In SURMOUNT-4, 36 weeks on the maximum tolerated dose of tirzepatide took a mean body weight of 107.3 kg down to 85.2 kg, about 49 lb. What that means at your own starting weight.
Read moreOctober 5, 2026
What the label says about a missed GLP-1 dose
Ozempic allows a missed dose within 5 days, Mounjaro and Zepbound within 4, and Wegovy injection asks how far away the next dose is. The labels side by side.
Read moreOctober 4, 2026
Protein intake on a GLP-1: how much and why
A joint advisory from the ACLM, ASN, OMA and The Obesity Society puts protein at 1.2 to 1.6 g per kg of body weight a day during active weight reduction, or 80 to 120 g a day as an absolute target.
Read moreOctober 4, 2026
Average weight loss on GLP-1 medications
In SURMOUNT-5, the only randomised head-to-head, tirzepatide averaged 20.2% of body weight over 72 weeks against 13.7% for semaglutide. Every published GLP-1 average, with its trial, dose, population and duration.
Read moreOctober 4, 2026
Zepbound dosage chart: what each dose delivers
Zepbound comes in six strengths from 2.5 mg to 15 mg. The label defines one starting dose, 2.5 mg for four weeks, with no conversion from semaglutide for people switching.
Read moreOctober 4, 2026
What a GLP-1 actually costs per month
Self-pay GLP-1 prices run from $149 to $449 a month in October 2026, but the dose ladder means year one costs more than twelve times the starting price. The full arithmetic, including cost per percentage point of weight lost.
Read moreOctober 4, 2026
Semaglutide units to mg: how the conversion works
Units on a U-100 syringe measure volume, not drug. mg = (units x mg per mL) / 100, so 25 units can be 0.25 mg or 2.5 mg depending on which vial it came from.
Read moreOctober 3, 2026
How much weight can you lose on Mounjaro?
Mounjaro’s SURPASS trials recorded 5.4 kg to 12.9 kg over 40 to 52 weeks in type 2 diabetes. SURMOUNT-2 recorded 14.7% at 15 mg over 72 weeks.
Read moreOctober 3, 2026
What to eat on a GLP-1
Published guidance puts protein above 60 to 75 g a day, fibre at 21 to 38 g and fluid above 2 to 3 litres, and names the foods that worsen side effects.
Read moreOctober 3, 2026
Storing and travelling with a GLP-1
Unopened, all four store at 36 to 46°F. Room temperature allowances differ: 56 days for Ozempic, 28 for Wegovy, 21 for Mounjaro and Zepbound.
Read moreOctober 3, 2026
Why GLP-1 weight loss plateaus, and what the trials show
In STEP 5, semaglutide weight loss plateaued around week 60 and held to week 104. Why the curve flattens, and what the trials show.
Read moreOctober 3, 2026
Tirzepatide dosing in units: the full conversion table
Every branded tirzepatide dose is 50 units on a single-dose vial and 60 units on a multi-dose vial. Full unit table by concentration.
Read moreOctober 2, 2026
How many calories to eat on a GLP-1
The trials behind every GLP-1 weight loss figure prescribed a diet about 500 kcal a day below estimated needs, plus 150 minutes of activity a week.
Read moreOctober 2, 2026
Muscle loss on a GLP-1 and how the trials measured it
In the SURMOUNT-1 DXA substudy, about 75% of the weight lost on tirzepatide was fat mass and 25% was lean mass, the same split the placebo arm showed.
Read moreOctober 2, 2026
Nausea on a GLP-1: why it happens and what the trials show
Nausea was reported by 44% of adults on Wegovy 2.4 mg and 25% to 29% of adults on Zepbound, against 8% to 16% on placebo. Here is when it peaks and why.
Read moreOctober 2, 2026
Ozempic pen click chart: what each click delivers
There is no official Ozempic click chart. The Instructions for Use tells patients not to set a dose by counting clicks, and the three pens hold three different concentrations.
Read moreOctober 2, 2026
What happens when you stop a GLP-1
A year after stopping semaglutide 2.4 mg, STEP 1 extension participants had regained 11.6 of the 17.3 percentage points they lost. What three withdrawal trials measured.
Read moreOctober 1, 2026
Alcohol on a GLP-1: what the evidence shows
The Ozempic label does not mention alcohol anywhere, and no interaction study was run. What the trials measured is the reverse question: whether semaglutide reduces drinking.
Read moreOctober 1, 2026
Hair loss on a GLP-1 or phentermine: the evidence
Phentermine labelling does not list hair loss at all. Semaglutide does: 3.3% on Wegovy 2.4 mg against 1% on placebo, rising to 5.8% at 7.2 mg, and the pattern tracks weight lost.
Read moreOctober 1, 2026
How does semaglutide work?
Semaglutide is a GLP-1 receptor agonist, and the effect that has actually been measured is reduced food intake: 24% lower across a day at 1 mg, 35% lower at a test meal on 2.4 mg.
Read moreOctober 1, 2026
Your first month on a GLP-1: what to expect
Wegovy starts at 0.25 mg against a 2.4 mg maintenance dose, and Zepbound at 2.5 mg against 5 to 15 mg. No published trial measured a starting dose as a treatment dose.
Read moreOctober 1, 2026
mg to mL for GLP-1 injections
2.5 mg is 0.5 mL from a 5 mg/mL vial and 0.125 mL from a 20 mg/mL vial. The conversion is the dose divided by the concentration, and the concentration is the whole answer.
Read moreSeptember 30, 2026
Where to inject a GLP-1 and why it matters
Abdomen, thigh and upper arm are the three labelled sites for semaglutide and tirzepatide, and both labels report similar exposure across all three.
Read moreSeptember 30, 2026
Mounjaro dosage chart and titration schedule
Mounjaro starts at 2.5 mg weekly and rises in 2.5 mg steps to a 15 mg maximum. SURPASS-1 cut HbA1c by 1.87 to 2.07 points over 40 weeks.
Read moreSeptember 30, 2026
How does tirzepatide work?
Tirzepatide agonises both the GIP and the GLP-1 receptor. SURMOUNT-1 recorded 20.9% mean weight loss at 15 mg over 72 weeks in adults without diabetes.
Read moreSeptember 30, 2026
Wegovy dosage chart: every step on the label
Wegovy injection steps 0.25, 0.5, 1 and 1.7 mg to a 2.4 mg maintenance dose at week 17, with 7.2 mg since March 2026. The tablets run 1.5 to 25 mg.
Read moreSeptember 29, 2026
The cheapest GLP-1 without insurance
Manufacturer self-pay prices start around $149 to $349 a month for semaglutide and $299 for Zepbound vials. What each programme costs and its conditions.
Read moreSeptember 29, 2026
How many units is 2.5 mg of tirzepatide?
It depends on the vial. 2.5 mg is 50 units from a 5 mg/mL vial, 25 from 10 mg/mL and 12.5 from 20 mg/mL. The formula and every common concentration.
Read moreSeptember 29, 2026
Ozempic dosage chart: the full titration schedule
Ozempic starts at 0.25 mg once weekly for 4 weeks, then 0.5 mg, then 1 mg, then a 2 mg ceiling. The labelled schedule and what each dose was tested at.
Read moreSeptember 29, 2026
Wegovy pill vs injection: how they compare
OASIS 4 recorded 13.6% weight loss on the 25 mg Wegovy pill over 64 weeks. STEP 1 recorded 14.9% on the 2.4 mg injection over 68. Two trials compared.
Read moreSeptember 29, 2026
Wegovy vs Ozempic: same drug, different ceiling
Both are semaglutide. Ozempic is licensed for type 2 diabetes to 2 mg, Wegovy for weight management to 2.4 mg. What the separate trials each measured.
Read moreSeptember 28, 2026
The best GLP-1 tracking apps in 2026
Jabby leads our GLP-1 tracker comparison on site rotation and prescriber exports. How it compares to Shotsy, Glapp, GlucoPal, Dosio and Pep.
Read moreSeptember 28, 2026
Semaglutide vs tirzepatide: what the head-to-head shows
SURMOUNT-5 recorded -20.2% on tirzepatide against -13.7% on semaglutide over 72 weeks. The randomised comparisons, and why cross-trial numbers are not one.
Read moreSeptember 28, 2026
How much weight can you lose on Zepbound?
In SURMOUNT-1, tirzepatide 15 mg averaged 20.9% weight loss over 72 weeks in adults with obesity and no diabetes. Full dose-by-dose trial data.
Read moreSeptember 28, 2026
Semaglutide side effects: what the trials recorded
Nausea affected 43.9% of participants on semaglutide 2.4 mg against 16.1% on placebo, with a median duration of 8 days. The recorded rates and how long they lasted.
Read moreSeptember 28, 2026
Tirzepatide side effects: rates from SURMOUNT-1
In SURMOUNT-1, adverse events caused 4.3% to 7.1% of tirzepatide participants to stop treatment against 2.6% on placebo. What the trials recorded, dose by dose.
Read moreSeptember 28, 2026
Semaglutide dosage chart: Ozempic vs Wegovy schedules
Ozempic tops out at 2 mg and Wegovy maintains at 2.4 mg. Both escalation schedules side by side, with the trial behind each ceiling.
Read moreSeptember 28, 2026
Tirzepatide dosage chart: 2.5 mg to 15 mg
Tirzepatide has six labelled doses from 2.5 mg to 15 mg in four-week steps. SURMOUNT-1 measured weight results at only three of them.
Read moreSeptember 25, 2026
mg to units: converting GLP-1 doses for syringes
Units on a U-100 syringe measure volume, not drug. Units = (mg / vial mg per mL) x 100, with worked examples at every common concentration.
Read moreSeptember 25, 2026
How much weight can you lose on Wegovy?
In STEP 1, semaglutide 2.4 mg averaged 14.9% weight loss over 68 weeks without diabetes, and 9.6% in STEP 2 with type 2 diabetes. Full trial data.
Read moreSeptember 21, 2026
Best GLP-1 dose conversion calculators compared 2026
No FDA-approved mg conversion exists between semaglutide and tirzepatide. What GLP-1 dose conversion tools actually do, and what to use instead.
Read moreSeptember 21, 2026
Best semaglutide dosing calculators ranked by accuracy 2026
The GLP1 Weight Loss Calculator ranks best for 2026, using STEP-1 and SURMOUNT-1 trial data. See how it compares to titration guides and telehealth tools.
Read moreSeptember 21, 2026
How much weight do you lose on Ozempic? Average results by month
Semaglutide averages about 6% weight loss by month 3 and 11% by month 6. See what the Ozempic trials actually measured, with sources.
Read more
